Clinical Trials Logo

Yeast Infection Vaginal clinical trials

View clinical trials related to Yeast Infection Vaginal.

Filter by:
  • None
  • Page 1

NCT ID: NCT03167957 Withdrawn - Clinical trials for Candidiasis, Vulvovaginal

Efficacy and Safety of Oral Encochleated Amphotericin B (CAMB) in the Treatment of Fluconazole-Resistant Vulvovaginal Candidiasis

Start date: December 2019
Phase: Phase 2
Study type: Interventional

This is a single-center, open-label, pilot study to evaluate the efficacy of 14 days of CAMB dosing in subjects with fluconazole-resistant vulvovaginal candidiasis (VVC).

NCT ID: NCT02971007 Completed - Clinical trials for Candidiasis, Vulvovaginal

Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)

Start date: November 2016
Phase: Phase 2
Study type: Interventional

This is a multi-center, randomized study to evaluate the safety, tolerability, and efficacy of 200 mg CAMB and 400 mg CAMB compared with a single 150 mg dose of fluconazole in the treatment of moderate to severe VVC.